Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles

The administration of microencapsulated drug in a matrix acid poly(lactic-co-glycolic acid) (PLGA) by intramuscular (IM) in humans has been approved by the FDA for various applications though it is not clear what effect they have on the morphological parameters of muscle tissue. The aim of this stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Acuña,Luis, Suazo Galdames,Iván, Zavando,Daniela, Elgueta,Samanta, Velásquez,Luis, Vilos,Cristian, Cantín,Mario
Lenguaje:English
Publicado: Sociedad Chilena de Anatomía 2011
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022011000200016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-95022011000200016
record_format dspace
spelling oai:scielo:S0717-950220110002000162011-07-22Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA MicroparticlesAcuña,LuisSuazo Galdames,IvánZavando,DanielaElgueta,SamantaVelásquez,LuisVilos,CristianCantín,Mario Skeletal muscle Drug delivery Polymeric microparticles PLGA The administration of microencapsulated drug in a matrix acid poly(lactic-co-glycolic acid) (PLGA) by intramuscular (IM) in humans has been approved by the FDA for various applications though it is not clear what effect they have on the morphological parameters of muscle tissue. The aim of this study was to analyze the morphological changes in the skeletal muscle tissue with their use. We used 12 adult female Sprague Dawley rats (Rattus novergicus) that were injected into their right gastrocnemius muscle belly with: sterile vehicle solution (G1, n = 4), 0.5 mg PLGA microparticle (G2, n = 4) and 0.75 mg PLGA microparticle (G3, n = 4), both dissolved in a sterile vehicle solution. At 14 days post injection the number and diameter of muscle fibers, the level of inflammation and histology appearance in terms of organization of muscle fibers, cellular distribution, tissue morphology and the presence of polymer waste were determined and the results between the groups compared. The administration of the compound in a single dose did not alter the morphometric parameters (number and diameter of muscle fibers) despite generating a mild inflammation in the tissue associated with the presence of polymeric residues, suggesting that the PLGA microparticles were well tolerated by the muscle tissue at concentrations tested (0.5 and 0.75 mg).info:eu-repo/semantics/openAccessSociedad Chilena de AnatomíaInternational Journal of Morphology v.29 n.2 20112011-06-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022011000200016en10.4067/S0717-95022011000200016
institution Scielo Chile
collection Scielo Chile
language English
topic Skeletal muscle
Drug delivery
Polymeric microparticles
PLGA
spellingShingle Skeletal muscle
Drug delivery
Polymeric microparticles
PLGA
Acuña,Luis
Suazo Galdames,Iván
Zavando,Daniela
Elgueta,Samanta
Velásquez,Luis
Vilos,Cristian
Cantín,Mario
Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles
description The administration of microencapsulated drug in a matrix acid poly(lactic-co-glycolic acid) (PLGA) by intramuscular (IM) in humans has been approved by the FDA for various applications though it is not clear what effect they have on the morphological parameters of muscle tissue. The aim of this study was to analyze the morphological changes in the skeletal muscle tissue with their use. We used 12 adult female Sprague Dawley rats (Rattus novergicus) that were injected into their right gastrocnemius muscle belly with: sterile vehicle solution (G1, n = 4), 0.5 mg PLGA microparticle (G2, n = 4) and 0.75 mg PLGA microparticle (G3, n = 4), both dissolved in a sterile vehicle solution. At 14 days post injection the number and diameter of muscle fibers, the level of inflammation and histology appearance in terms of organization of muscle fibers, cellular distribution, tissue morphology and the presence of polymer waste were determined and the results between the groups compared. The administration of the compound in a single dose did not alter the morphometric parameters (number and diameter of muscle fibers) despite generating a mild inflammation in the tissue associated with the presence of polymeric residues, suggesting that the PLGA microparticles were well tolerated by the muscle tissue at concentrations tested (0.5 and 0.75 mg).
author Acuña,Luis
Suazo Galdames,Iván
Zavando,Daniela
Elgueta,Samanta
Velásquez,Luis
Vilos,Cristian
Cantín,Mario
author_facet Acuña,Luis
Suazo Galdames,Iván
Zavando,Daniela
Elgueta,Samanta
Velásquez,Luis
Vilos,Cristian
Cantín,Mario
author_sort Acuña,Luis
title Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles
title_short Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles
title_full Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles
title_fullStr Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles
title_full_unstemmed Morphometric and Histopathologic Changes in Skeletal Muscle Induced for Injectable PLGA Microparticles
title_sort morphometric and histopathologic changes in skeletal muscle induced for injectable plga microparticles
publisher Sociedad Chilena de Anatomía
publishDate 2011
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022011000200016
work_keys_str_mv AT acunaluis morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
AT suazogaldamesivan morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
AT zavandodaniela morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
AT elguetasamanta morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
AT velasquezluis morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
AT viloscristian morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
AT cantinmario morphometricandhistopathologicchangesinskeletalmuscleinducedforinjectableplgamicroparticles
_version_ 1718444729313525760